Evolution of the Artificial Pancreas: Components and Integration-CGMs, Insulin, and AP Systems. [PDF]
Bergenstal RM +18 more
europepmc +1 more source
Dual-hormone artificial pancreas for glucose control in type 1 diabetes: A meta-analysis. [PDF]
Zeng B +5 more
europepmc +1 more source
Synergistic isoflavone‐probiotic action modulated metabolic, microbial and ovarian pathway ABSTRACT Polycystic ovary syndrome (PCOS) is a prevalent metabolic–endocrine disorder characterized by insulin resistance, hyperandrogenism, chronic inflammation, oxidative stress, and ovarian dysfunction, with growing evidence implicating gut microbiota ...
Jeyavelkumaran Renukadevi +4 more
wiley +1 more source
The 'Designer' Artificial Pancreas: How Does Current Technology Mimic Pancreatic Physiology? [PDF]
Ayliffe Daly L.
europepmc +1 more source
Medicinal Pasta Alleviates Oxidative Stress and Metabolic Complications in Diabetic Rats
Composite ratio mixture of wheat, unripe plantain and moringa flours used to produce pasta modulated lipid profile, related glucose metabolic enzymes, and antioxidant in diabetic rats. ABSTRACT Medicinal plant‐based foods from natural sources with antioxidant properties, cholesterol, blood glucose, and blood pressure reducing properties are rarely ...
Bukola Christiana Adedayo +4 more
wiley +1 more source
Time course change of the insulin requirements during the perioperative period in hepatectomy and pancreatectomy by using an artificial pancreas STG-55. [PDF]
Teshigawara S +13 more
europepmc +1 more source
Advanced extracellular vesicle immunotherapy
A diagrammatic depiction of the therapeutic applicability of extracellular vesicles (EVs) in immunotherapy. This review explores the dual roles of tumor‐derived and immune cell‐derived EVs in cancer immunotherapy, discusses recent progress in EV engineering that improve their clinical utility, and evaluates their potential to augment existing ...
Jingjing Zhang +6 more
wiley +1 more source
Event-triggered smart dual hormone artificial pancreas for patient-specific drug delivery. [PDF]
Govindaraju D, Subbian S.
europepmc +1 more source
In-silico evaluation of an artificial pancreas achieving automatic glycemic control in patients with type 1 diabetes. [PDF]
Liu W, Chen T, Liang B, Wang Y, Jin H.
europepmc +1 more source
Whey protein‐based microencapsulation for omega‐3 PUFA delivery in food systems. Objective: Enhance oxidative stability & bioavailability of omega‐3 PUFAs using whey protein as an encapsulating agent. Current methods: Spray drying & coacervation—effective but limited by heat sensitivity and encapsulation efficiency. Emerging technologies: Electrospray &
Jihan M. Kassem +9 more
wiley +1 more source

